Question 1

Does Mercer Global Advisors own ORKA stock?

Accepted Answer

No. Mercer Global Advisors exited its ORKA (Oruka Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 802,470 shares worth $39.4M.

Question 2

How many shares of ORKA does Mercer Global Advisors own?

Accepted Answer

None since Q2 2026, when Mercer Global Advisors exited the position. Its Q1 2026 13F listed 802,470 shares worth $39.4M.

Question 3

What is Mercer Global Advisors' ORKA position worth?

Accepted Answer

Mercer Global Advisors' ORKA position was worth $39.4M in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Mercer Global Advisors buying or selling ORKA?

Accepted Answer

In Q2 2026, Mercer Global Advisors exited its entire ORKA position.

Question 5

When did Mercer Global Advisors first buy ORKA?

Accepted Answer

Mercer Global Advisors first reported ORKA in its Q2 2025 13F and listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$95.17	0
2026-Q1	Increased	802,470	+7.7%	$39.4M	0.1%	$49.05	31
2025-Q4	Decreased	745,277	-12.6%	$22.6M	0.0%	$30.31	0
2025-Q3	Increased	852,411	+0.0%	$16.4M	0.0%	$19.23	28
2025-Q2	New	852,338	—	$9.6M	0.0%	$11.21	38